Variant · Snv
RET NM_020975.6(RET):c.3188-9C>T
CI-VAR-00022097Explore in graph →NM_020975.6:c.3188-9C>TClinVar 136116 rs551159582
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 136116 | Benign/Likely benign | criteria provided, multiple submitters, no conflicts | 2 | Multiple endocrine neoplasia, type 2; Multiple endocrine neoplasia type 2B; Multiple endocrine neoplasia type 2A; Renal hypodysplasia/aplasia 1; Hirschsprung disease, susceptibility to, 1; Pheochromocytoma; Multiple endocrine neoplasia; Hereditary cancer-predisposing syndrome; Familial hyperparathyroidism or Hypocalciuric hypercalcaemia | germline | 8 | Feb 04, 2026 | clinvar |